IMVT NASDAQ
Immunovant, Inc.
1W: +1.0%
1M: -14.9%
3M: -12.9%
YTD: +29.8%
1Y: +105.8%
3Y: -14.9%
5Y: +288.7%
$33.62
-0.03 (-0.09%)
Weekly Expected Move ±4.8%
$30
$32
$34
$35
$37
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-506M
Net Income
-22.2% YoY
$-407M
Free Cash Flow
-8.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-64.8%
ROA-58.3%
ROIC851.4%
Valuation
P/E-11.9
P/B9.4
EV/EBITDA-8.2
Leverage
Debt/Equity0.00
Current Ratio9.09
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z25.69
Beneish M0.00